A systematic review of PDE-5 inhibitors for erectile dysfunction was performed to evaluate the utility of quantitative methods for identifying and exploring the influence of bias and study quality on ...

CORVALLIS, Ore., May 8, 2025 /PRNewswire/ -- Karma Biosciences announced today that it has applied for patent protection for two new drug formulations utilizing its proprietary excipient Zenergy™ .

Continuing high fuel costs and growing environmental pressures could inject new urgency into development of pulse-detonation engine (PDE) technology for wider commercial applications, rather than just ...